Find clinical trials for Breast Cancer in Warszawa, Mazowieckie
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Warszawa, Mazowieckie, POL:
adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast...
Phase 2
Warsaw, Poland and 72 other locations
The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations in patients with ER+/HER2- advanced/metastatic breast...
Phase 1, Phase 2
Warszawa, Mazowieckie, Poland and 116 other locations
look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...
Phase 3
Warszawa, Poland and 145 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Warszawa, Mazowieckie, Poland and 317 other locations
in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple negative breast...
Phase 1, Phase 2
Warszawa, Poland and 31 other locations
with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...
Phase 3
Warszawa, Poland and 166 other locations
(BMs), with previously-treated advanced/metastatic HER2-positive breast cancer whose disease has progressed on prior anti-HER2-base...
Phase 3
Warszawa, Poland and 80 other locations
ribociclib or abemaciclib with letrozole) in people with breast cancer:* HR-positive (breast cancer cells that ne...
Phase 3
Otwock, Poland and 254 other locations
endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast...
Phase 3
Warszawa, Mazowieckie, Poland and 302 other locations
for the treatment of participants with metastatic HER2-positive breast cancer who have progressed on, or are intolerant to, previou...
Phase 3
Warszawa, Poland and 143 other locations
Clinical trials
Research sites
Resources
Legal